Õý°æ²¶ÓãÓÎÏ·¹Ù·½ÍøÕ¾´óÈ«

ÓÐÎʱشð

ËÑË÷´ð°¸

ÓÐÎʱشð > ÄÚ¿Æ > ÂýÐÔÁ£µ¥ºËϸ°û°×Ѫ²¡

ÂýÐÔÁ£µ¥ºËϸ°û

ÂýÐÔÁ£µ¥ºËϸ°û°×Ѫ²¡

|Óû§¹Ø×¢¶È£º

ÖÜ0% ÔÂ0%
ÂýÐÔÁ£µ¥ºËϸ°û°×Ѫ²¡(Chronicmyelomonocyticleukaemia£¬CMML)ÊÇÒ»ÖÖÂýÐÔËèϵ°×Ѫ²¡¡£·¢²¡ÂÊԼΪ1¡«2/100000/Ä꣬¶àÊýÔÚ60ËêÒÔºó·¢²¡£¬ÄÐÅ®·¢²¡±ÈÀýÔ¼1.5¡«3£º1¡£²é¿´Ïêϸ
ÔÝʱûÓзûºÏÄúËÑË÷µÄÊý¾ÝŶ~£¡
Ïà¹Ø±êÇ©
  • °×Ѫ²¡
  • ¼±ÐÔ°×Ѫ²¡
  • ÂýÐÔËèϸ°ûÐÔ°×Ѫ²¡
  • ¼±ÐÔÁܰÍϸ°û°×Ѫ²¡
  • ÂýÐÔÁܰÍϸ°û°×Ѫ²¡
  • µ¥ºËϸ°û°×Ѫ²¡
  • ¼±ÐÔÁܰÍϸ°ûÐÔ°×Ѫ²¡
  • ¼±ÐÔÔçÓ×Á£Ï¸°û°×Ѫ²¡
  • ¼±ÐÔËèϸ°û°×Ѫ²¡
  • ¼±ÐÔ·ÇÁܰÍϸ°û°×Ѫ²¡
  • ÂýÐÔÁ£Ï¸°ûÐÔ°×Ѫ²¡
  • ëϸ°û°×Ѫ²¡

ÄãÖªµÀÂð£¿

ÎÒÏëÎÊһϣ¬Ó×¶ùÂýÐÔÁ£µ¥ºËϸ°û

Ö¸µ¼Òâ¼û£ºÄãºÃ£¬ÄÇÒªÊÇÄãÕâ¸öСº¢ÓÐÕâ¸ö¼²²¡ÊÇÐèÒª×ö¹Ç´©ºÍ»ùÒò¼ì²é¿´[Ïêϸ]

ÂýÐÔÁ£µ¥ºËϸ°û°×Ѫ²¡µÄѪ³£¹æÖÐ

Ö¸µ¼Òâ¼û£ºÄúºÃ£¬Ñª³£¹æÒ»°ã2-5³Æ109£¬Ô¼Õ¼°×ϸ°û¼ÆÊýµÄÁܰÍϸ°û¿ÉÒÔÕý[Ïêϸ]

ÂýÐÔÁ£µ¥ºËϸ°û°×Ѫ²¡ÄÜ·ñÖÎÓúÂð

Ö¸µ¼Òâ¼û£ºÄãºÃ£¬Ò»°ãÐèÒª¾ÍÒ½Ö¸µ¼½øÐÐÕë¶ÔÐÔµÄÃâÒßÐÞ¸´Õý°æ²¶ÓãÓÎÏ·¹Ù·½ÍøÕ¾´óÈ«£¬ÐèÒª×öºÃ[Ïêϸ]

Õý°æ²¶ÓãÓÎÏ·(Öйú)app¹Ù·½ÏÂÔØ|Õý°æ²¶ÓãÓÎÏ·¹Ù·½ÍøÕ¾